MAGRX
Price
$34.01
Change
-$0.41 (-1.19%)
Updated
Dec 2 closing price
Net Assets
154.55M
PRNEX
Price
$43.67
Change
-$0.27 (-0.61%)
Updated
Dec 2 closing price
Net Assets
2.49B
Interact to see
Advertisement

MAGRX vs PRNEX

Header iconMAGRX vs PRNEX Comparison
Open Charts MAGRX vs PRNEXBanner chart's image
BlackRock Natural Resources Instl
Price$34.01
Change-$0.41 (-1.19%)
VolumeN/A
Net Assets154.55M
T. Rowe Price New Era
Price$43.67
Change-$0.27 (-0.61%)
VolumeN/A
Net Assets2.49B
MAGRX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
MAGRX vs. PRNEX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAGRX is a Buy and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.49B vs. MAGRX (155M). MAGRX pays higher dividends than PRNEX: MAGRX (2.39) vs PRNEX (1.77). MAGRX was incepted earlier than PRNEX: MAGRX (37 years) vs PRNEX (57 years). MAGRX (0.91) is less costly to investors than PRNEX (0.77). MAGRX is a more actively managed with annual turnover of: 79.00 vs. PRNEX (24.30). PRNEX has a lower initial minimum investment than MAGRX: PRNEX (2500) vs MAGRX (2000000). MAGRX annual gain was more profitable for investors over the last year : 8.46 vs. PRNEX (6.24). MAGRX return over 5 years is better than : 57.66 vs. PRNEX (51.77).
MAGRXPRNEXMAGRX / PRNEX
Total Expense Ratio0.910.77118%
Annual Report Gross Expense Ratio0.910.77118%
Fund Existence37 years57 years-
Gain YTD19.45918.245107%
Front LoadN/AN/A-
Min. Initial Investment2000000250080,000%
Min. Initial Investment IRAN/AN/A-
Net Assets155M2.49B6%
Annual Yield % from dividends2.391.77135%
Returns for 1 year8.466.24136%
Returns for 3 years6.347.7282%
Returns for 5 years57.6651.77111%
Returns for 10 years-2.2673.31-3%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGGX28.87N/A
N/A
American Century Global Gold A
LAFQX21.15N/A
N/A
Lord Abbett Affiliated R2
SHPAX22.62N/A
N/A
Saratoga Health & Biotechnology A
GCVCX25.65N/A
N/A
Goldman Sachs Large Cp Val Insghts C
JOSSX53.69N/A
N/A
Johnson Opportunity S